Biocon Biologics Integrates Viatris Business As It Introduces Adalimumab

Completes ‘First Wave’ Of Viatris Integration And Launches US Hulio Rival To Humira

 
• By David Wallace
  
Biocon logo with silhouette of vials and syringe
Multiple developments have been seen for Biocon’s biosimilars business • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products